Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
Affinia Therapeutics raises $110 million for gene therapy treatments ( STAT ). Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ). BD Taps Contract Packager for COVID-19 Test Kits ( MD+DI ). Medtech. Medtech.
52 
Let's personalize your content